These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 2114365

  • 1. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.
    Fattom A, Schneerson R, Szu SC, Vann WF, Shiloach J, Karakawa WW, Robbins JB.
    Infect Immun; 1990 Jul; 58(7):2367-74. PubMed ID: 2114365
    [Abstract] [Full Text] [Related]

  • 2. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.
    Fattom A, Schneerson R, Watson DC, Karakawa WW, Fitzgerald D, Pastan I, Li X, Shiloach J, Bryla DA, Robbins JB.
    Infect Immun; 1993 Mar; 61(3):1023-32. PubMed ID: 8432585
    [Abstract] [Full Text] [Related]

  • 3. Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid.
    Fattom A, Lue C, Szu SC, Mestecky J, Schiffman G, Bryla D, Vann WF, Watson D, Kimzey LM, Robbins JB.
    Infect Immun; 1990 Jul; 58(7):2309-12. PubMed ID: 2365462
    [Abstract] [Full Text] [Related]

  • 4. Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides.
    Fattom A, Li X, Cho YH, Burns A, Hawwari A, Shepherd SE, Coughlin R, Winston S, Naso R.
    Vaccine; 1995 Oct; 13(14):1288-93. PubMed ID: 8585282
    [Abstract] [Full Text] [Related]

  • 5. Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate.
    Fattom A, Shiloach J, Bryla D, Fitzgerald D, Pastan I, Karakawa WW, Robbins JB, Schneerson R.
    Infect Immun; 1992 Feb; 60(2):584-9. PubMed ID: 1730492
    [Abstract] [Full Text] [Related]

  • 6. Preclinical laboratory evaluation of a bivalent Staphylococcus aureus saccharide-exotoxin A protein conjugate vaccine.
    Ho MM, Bolgiano B, Martino A, Kairo SK, Corbel MJ.
    Hum Vaccin; 2006 Feb; 2(3):89-98. PubMed ID: 17012902
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates.
    Cryz SJ, Lang AB, Sadoff JC, Germanier R, Fürer E.
    Infect Immun; 1987 Jul; 55(7):1547-51. PubMed ID: 3110065
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
    Fattom AI, Sarwar J, Ortiz A, Naso R.
    Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL.
    Schneerson R, Fattom A, Szu SC, Bryla D, Ulrich JT, Rudbach JA, Schiffman G, Robbins JB.
    J Immunol; 1991 Oct 01; 147(7):2136-40. PubMed ID: 1918948
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins.
    Cryz SJ, Fürer E, Sadoff JC, Germanier R, Pastan I, Willingham MC, FitzGerald DJ.
    Rev Infect Dis; 1987 Oct 01; 9 Suppl 5():S644-9. PubMed ID: 3120274
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and some immunologic properties of an O-acetyl pectin [poly(1-->4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever.
    Szu SC, Bystricky S, Hinojosa-Ahumada M, Egan W, Robbins JB.
    Infect Immun; 1994 Dec 01; 62(12):5545-9. PubMed ID: 7960137
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies.
    El-Zaim HS, Chopra AK, Peterson JW, Vasil ML, Heggers JP.
    Infect Immun; 1998 Nov 01; 66(11):5551-4. PubMed ID: 9784572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.